These observations altogether suggest that, in the context of cardiovascular disease, the extent of CRP elevation predicts the extent of atherosclerotic inflammation, thereby making CRP level a suitable primary outcome parameter for our study. The gene discussed is CRP; the disease is cardiovascular disorder.